Bio-Rad Laboratories, Inc.

Healthcare

NYSE:BIO · New York Stock Exchange

Market Cap $7.91B Beta 1.08 P/E (TTM) 45.5

$285.94 -2.61%

-$7.63 today

52W Low $222.80High $343.12

Vol 0.13M · Avg 0.38M

EPS (TTM)$6.26

Medical - Devices

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+26.01%

Period High

$339.75

Period Low

$226.91

Latest

$285.94

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

DaVita Inc.

NYSE:DVA

$13.45B

Penumbra, Inc.

NYSE:PEN

$12.53B

Align Technology, Inc.

NASDAQ:ALGN

$12.51B

Globus Medical, Inc.

NYSE:GMED

$10.86B

Masimo Corporation

NASDAQ:MASI

$9.42B

Henry Schein, Inc.

NASDAQ:HSIC

$9.31B

Charles River Laboratories International, Inc.

NYSE:CRL

$9.06B

AptarGroup, Inc.

NYSE:ATR

$7.51B

HealthEquity, Inc.

NASDAQ:HQY

$7.38B

Grifols, S.A.

NASDAQ:GRFS

$6.50B

What is the latest BIO filing?

The latest filing shown is SD dated May 13, 2026.

How many recent filings does BIO have?

Intrinsic Alpha currently shows 20 recent filings for BIO.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.